Target intelligence / Profile preview

Photoreceptor cell in the retina (None commonly used for the general cell type; specific photoreceptor subtypes have abbreviations (e.g., rod cell, cone cell), but for the overall class, there is no standard abbreviation)

Target
None commonly used for the general cell type; specific photoreceptor subtypes have abbreviations (e.g., rod cell, cone cell), but for the overall class, there is no standard abbreviation
Molecular classification
Other (specialized neuron/neuroepithelial cell), G protein–coupled receptor (e.g., rhodopsin, photopsin, melanopsin)
01

Overview

Photoreceptor cells are specialized neuroepithelial cells located in the retina, responsible for the transduction of light into neural signals that the brain interprets as vision. There are three main classes: - Rod cells: detect low light and provide night vision (scotopic vision). - Cone cells: provide color vision and high visual acuity (photopic vision) and are subdivided into blue, green, and red-sensitive types. - Photosensitive retinal ganglion cells: contain melanopsin and are involved in non-image-forming light responses, such as circadian rhythm regulation and pupillary reflex. These cells contain molecular machinery (e.g., opsins, voltage-gated channels) that absorb photons and trigger a biochemical cascade, converting light into graded electrical signals. Photoreceptors are crucial for making vision possible and are implicated in various retinal diseases. While not considered a molecular drug target themselves, their function depends on underlying molecular pathways that can be targeted therapeutically (e.g., opsins, chromophore cycle proteins).

Other names
Retinal photoreceptor cellRod cell (for scotopic vision)Cone cell (for color vision)Photosensitive retinal ganglion cell (for circadian and other non-image-forming vision)
02

Mechanism of action

Varies by molecular target: e.g., gene therapy restores functional opsin proteins, vitamin A supplementation supports retinal chromophore production, neuroprotective strategies aim to slow cell death. Photoreceptor cell replacement (cell therapy/regeneration) is investigational

03

Biological functions

Phototransduction (conversion of light to electrical signal)Visual perception (image formation, color vision, acuity)Circadian rhythm regulation (by photosensitive retinal ganglion cells)Signal transduction (in the context of nervous system signaling)Other non-image-forming light perception (pupillary reflex, melatonin suppression)
04

Disease associations

Neurodegenerative disease (inherited retinal degenerations such as retinitis pigmentosa, cone-rod dystrophy)Other (vitamin A deficiency leading to blindness; age-related macular degeneration; diabetic retinopathy; retinal detachment)
05

Safety considerations

Loss of photoreceptor cells leads to blindness; therapeutic challenges include cell survival, immune rejection (for regenerative/cell therapies), specificity of molecular interventions, potential off-target toxicity for gene therapiesVitamin A toxicity or deficiency in modulating retinal health; inability to regenerate cells once lost makes vision loss irreversible in most cases
06

Interacting drugs

None directly target the cell type itself; interventions act on molecular components (e.g., gene therapy for RPE65 mutation/restoration of functional photoreceptors, drugs targeting opsin-related pathways in rare diseases)

2 more in the full profile.

07

Biomarkers

None for the cell type; disease states may use visual acuity, electroretinogram (ERG), optical coherence tomography (OCT) as indirect markers of photoreceptor cell function/densityMolecular biomarkers used for specific pathways: opsin protein levels (immunohistochemistry), genetic mutations (e.g., RPE65; determined by genetic testing)

Beyond the preview

Go deeper on Photoreceptor cell in the retina (None commonly used for the general cell type; specific photoreceptor subtypes have abbreviations (e.g., rod cell, cone cell), but for the overall class, there is no standard abbreviation).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Photoreceptor cell in the retina (None commonly used for the general cell type; specific photoreceptor subtypes have abbreviations (e.g., rod cell, cone cell), but for the overall class, there is no standard abbreviation).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call